These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

901 related items for PubMed ID: 19342598

  • 1. Late outgrowth endothelial cells derived from Wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epithelium-derived factor.
    Wang SH, Lin SJ, Chen YH, Lin FY, Shih JC, Wu CC, Wu HL, Chen YL.
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):816-22. PubMed ID: 19342598
    [Abstract] [Full Text] [Related]

  • 2. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy.
    Wang CH, Ciliberti N, Li SH, Szmitko PE, Weisel RD, Fedak PW, Al-Omran M, Cherng WJ, Li RK, Stanford WL, Verma S.
    Circulation; 2004 Mar 23; 109(11):1392-400. PubMed ID: 14993120
    [Abstract] [Full Text] [Related]

  • 3. Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury.
    Wang CH, Cherng WJ, Yang NI, Kuo LT, Hsu CM, Yeh HI, Lan YJ, Yeh CH, Stanford WL.
    Arterioscler Thromb Vasc Biol; 2008 Jan 23; 28(1):54-60. PubMed ID: 17991877
    [Abstract] [Full Text] [Related]

  • 4. Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: Potential contribution of bone-marrow-derived progenitors to arterial remodeling.
    Shoji M, Sata M, Fukuda D, Tanaka K, Sato T, Iso Y, Shibata M, Suzuki H, Koba S, Geshi E, Katagiri T.
    Cardiovasc Pathol; 2004 Jan 23; 13(6):306-12. PubMed ID: 15556776
    [Abstract] [Full Text] [Related]

  • 5. Potent inhibitory effect of sirolimus on circulating vascular progenitor cells.
    Fukuda D, Sata M, Tanaka K, Nagai R.
    Circulation; 2005 Feb 22; 111(7):926-31. PubMed ID: 15710768
    [Abstract] [Full Text] [Related]

  • 6. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro.
    Sakata Y, Xiang F, Chen Z, Kiriyama Y, Kamei CN, Simon DI, Chin MT.
    Arterioscler Thromb Vasc Biol; 2004 Nov 22; 24(11):2069-74. PubMed ID: 15345511
    [Abstract] [Full Text] [Related]

  • 7. Transfusion of autologous late-outgrowth endothelial cells reduces arterial neointima formation after injury.
    Liu SQ, Li ZL, Cao YX, Li L, Ma X, Zhao XG, Kang AQ, Liu CH, Yuan BX.
    Cardiovasc Res; 2011 Apr 01; 90(1):171-81. PubMed ID: 21163831
    [Abstract] [Full Text] [Related]

  • 8. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy.
    Griese DP, Ehsan A, Melo LG, Kong D, Zhang L, Mann MJ, Pratt RE, Mulligan RC, Dzau VJ.
    Circulation; 2003 Nov 25; 108(21):2710-5. PubMed ID: 14597586
    [Abstract] [Full Text] [Related]

  • 9. The ratio of VEGF/PEDF expression in bone marrow mesenchymal stem cells regulates neovascularization.
    Fan W, Crawford R, Xiao Y.
    Differentiation; 2011 Mar 25; 81(3):181-91. PubMed ID: 21236558
    [Abstract] [Full Text] [Related]

  • 10. Pigment epithelium-derived factor acts as an opponent of growth-stimulatory factors in retinal glial-endothelial cell interactions.
    Yafai Y, Lange J, Wiedemann P, Reichenbach A, Eichler W.
    Glia; 2007 Apr 15; 55(6):642-51. PubMed ID: 17309061
    [Abstract] [Full Text] [Related]

  • 11. Deficiency of tumour necrosis factor-alpha and interferon-gamma in bone marrow cells synergistically inhibits neointimal formation following vascular injury.
    Murayama H, Takahashi M, Takamoto M, Shiba Y, Ise H, Koyama J, Tagawa Y, Iwakura Y, Ikeda U.
    Cardiovasc Res; 2008 Nov 01; 80(2):175-80. PubMed ID: 18791204
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth muscle-like progenitor cells.
    Yamada T, Kondo T, Numaguchi Y, Tsuzuki M, Matsubara T, Manabe I, Sata M, Nagai R, Murohara T.
    Arterioscler Thromb Vasc Biol; 2007 Nov 01; 27(11):2363-9. PubMed ID: 17717297
    [Abstract] [Full Text] [Related]

  • 13. Role of vessel wall and bone marrow syndecan-4 in neointimal hyperplasia: the plot thickens.
    Caplice NM.
    Arterioscler Thromb Vasc Biol; 2011 May 01; 31(5):952-3. PubMed ID: 21508338
    [No Abstract] [Full Text] [Related]

  • 14. Human umbilical cord-derived endothelial progenitor cells promote growth cytokines-mediated neorevascularization in rat myocardial infarction.
    Hu CH, Li ZM, DU ZM, Zhang AX, Yang DY, Wu GF.
    Chin Med J (Engl); 2009 Mar 05; 122(5):548-55. PubMed ID: 19323906
    [Abstract] [Full Text] [Related]

  • 15. Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice.
    Yoshioka T, Takahashi M, Shiba Y, Suzuki C, Morimoto H, Izawa A, Ise H, Ikeda U.
    Cardiovasc Res; 2006 Apr 01; 70(1):61-9. PubMed ID: 16448633
    [Abstract] [Full Text] [Related]

  • 16. Time-course analysis on the differentiation of bone marrow-derived progenitor cells into smooth muscle cells during neointima formation.
    Daniel JM, Bielenberg W, Stieger P, Weinert S, Tillmanns H, Sedding DG.
    Arterioscler Thromb Vasc Biol; 2010 Oct 01; 30(10):1890-6. PubMed ID: 20576944
    [Abstract] [Full Text] [Related]

  • 17. Protective role of clusterin/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells.
    Kim HJ, Yoo EK, Kim JY, Choi YK, Lee HJ, Kim JK, Jeoung NH, Lee KU, Park IS, Min BH, Park KG, Lee CH, Aronow BJ, Sata M, Lee IK.
    Arterioscler Thromb Vasc Biol; 2009 Oct 01; 29(10):1558-64. PubMed ID: 19696405
    [Abstract] [Full Text] [Related]

  • 18. Expression of HIF-1alpha in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E deficient mice.
    Karshovska E, Zernecke A, Sevilmis G, Millet A, Hristov M, Cohen CD, Schmid H, Krotz F, Sohn HY, Klauss V, Weber C, Schober A.
    Arterioscler Thromb Vasc Biol; 2007 Dec 01; 27(12):2540-7. PubMed ID: 17932320
    [Abstract] [Full Text] [Related]

  • 19. Expression of vascular endothelial growth factor receptor-2 or Tie-2 on peripheral blood cells defines functionally competent cell populations capable of reendothelialization.
    Nowak G, Karrar A, Holmén C, Nava S, Uzunel M, Hultenby K, Sumitran-Holgersson S.
    Circulation; 2004 Dec 14; 110(24):3699-707. PubMed ID: 15381639
    [Abstract] [Full Text] [Related]

  • 20. Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia.
    Urao N, Okigaki M, Yamada H, Aadachi Y, Matsuno K, Matsui A, Matsunaga S, Tateishi K, Nomura T, Takahashi T, Tatsumi T, Matsubara H.
    Circ Res; 2006 Jun 09; 98(11):1405-13. PubMed ID: 16645141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.